← Russell 3000 cross-section

LFST LifeStance Health Group, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$4.7bn
Revenue TTM
$1.6bn
Net income TTM
$51m
Free cash flow
$174m
Composite score
47.9
Sector rank
#1124

Valuation

P / E
92.8
EV / EBITDA
39.2
EV / sales
3.0
FCF yield
3.70%
Earnings yield vs 10-yr
-3.65pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
3.2%
EBITDA margin
7.6%
ROE
3.4%
ROIC
5.2%
Revenue growth
20.4%

Insider activity, last 90 days

Net open-market
$-161.05m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We generate lower revenue and experience lower clinician productivity in periods that have fewer business days than other periods. We seek to grow our Center Margin through a combination of (i) growing revenue through clinician hiring and retention, patient growth and engagement, hybrid virtual and in-person care, existing office expansion, and in-network reimbursement levels, and (ii) leveraging on our fixed cost base at each center. …LifeStance Health Group, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →